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Cell cycle investigations have focused on relentless exponential proliferation of cells, an unsustain-
able situation in nature. Proliferation of cells, whether microbial or metazoan, is interrupted by
periods of quiescence. The vast majority of cells in an adult metazoan lie quiescent. As disruptions
in this quiescence are at the foundation of cancer, it will be important for the ﬁeld to turn its atten-
tion to the mechanisms regulating quiescence. While often presented as a single topic, there are
multiple forms of quiescence each with complex inputs, some of which are tied to conceptually chal-
lenging aspects of metazoan regulation such as size control. In an effort to expose the enormity of
the challenge, I describe the differing biological purposes of quiescence, and the coupling of quies-
cence in metazoans to growth and to the structuring of tissues during development. I emphasize
studies in the organism rather than in tissue culture, because these expose the diversity of regulation.
While quiescence is likely to be a primitive biological process, it appears that in adapting quiescence
to its many distinct biological settings, evolution has diversiﬁed it. Consideration of quiescence
in different models gives us an overview of this diversity.
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1. INTRODUCTION
Most cells of an adult metazoan have exited the cell
cycle and generally lie quiescent unless called upon
to replace cells lost to injury or turnover, or unless
an oncogenic change disrupts the quiescence and
drives pathological proliferation. This quiescence is
central to normal metazoan biology and its disrup-
tions underlie cancer. However, the cell cycle ﬁeld
has largely focused on experimental systems exhibiting
unchecked growth and proliferation. It is increasingly
recognizedthatanunderstandingofcellcycleregulation
in its normal context will beneﬁt from a focus on the
regulation of quiescence and its disruptions. But, I
think the magnitude of this question is not widely
appreciated. Here, I suggest that it is a huge biological
issue that will interface tightly with development, as
well as nutrition, evolution and cancer biology. In this
respect, research into this area appears to be poised for
major expansion. I highlight the expanse of the topic
by focusing on the complexity of quiescence in the
metazoancontextandIconsider theoptimisticperspec-
tive that quiescence, as practised in various simple
models, will deﬁne a global mechanism that is relevant
from yeast to mammals.
The term quiescence has been used to cover a broad
range of circumstances, which obfuscates comparisons
between organisms. There are numerous biological
uses for quiescence, as well as different forms of it.
I outline some of each of these as groundwork for a
discussion of the possible connections between the
quiescence practised in different organisms. We will
see that organisms possess multiple forms of quiescence
and selectively engage these at different times to achieve
outcomes suited to their lifestyle.
Rapidly growing cells have much in common, as
they all actively express growth genes, such as genes
encoding machinery that makes more protein ([1,2];
O’Farrell 1976, unpublised data). In contrast, quies-
cent cells are free to adopt any specialization and can
differ dramatically [2,3]. Indeed, the major deﬁning
feature of the ‘state of quiescence’ is that quiescent
cells do not engage in one or more activities practised
by non-quiescent cells. Additionally, there is a diversity
of signals that trigger quiescence in different systems.
If there are global generalities to be made, then they
are likely to appear in the mechanisms that are called
forth to shut down activities associated with growth.
2. THE ORIGINS OF QUIESCENCE
There are strong arguments favouring the notion that
quiescence makes integral contributions to biological
success and it is likely to have evolved early. It has
long been recognized that successful exponential
growth will inevitably surmount the supplies needed
to support it. It was recognition of this tension that
motivated Thomas Malthus’s inﬂuential ‘An Essay
on the Principle of Population’, which starkly pre-
sented the challenges of human population growth
for society. However, the tension is universal, and
was recognized by Malthus who wrote ‘The cause to
which I allude, is the constant tendency in all animated
life to increase beyond the nourishment prepared for
it’ [4, p. 2]. This tension impacts all life forms and it
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survive the limitation that is inevitable.
A little mental exercise illustrates the tension between
growth and resources in a prokaryotic context. I do not
remember where I ﬁrst heard about this simple calcu-
lation, but I have conﬁrmed it myself, and I never cease
to ﬁnd it impressive [5]. A single Escherichia coli weighs
about 10
212 g[ 6]. If well fed, it will double every
20 min and conveniently grows quickly to numbers ade-
quate for experimental purposes. But, consider the
consequences of three doublings per hour if you could
keep E. coli well fed for just a little longer than our
usual cultures. In 24 h (72 doublings), you would have
4000 metric tonnes of E. coli (10
212 g  2
72). In 2
days, the mass of E. coli (1.6  10
28 kg) would be
larger than the mass of the Earth (6  10
24 kg) and
in 3 days this mass would have grown to occupy a
volume (at 1g c m
23 this ¼ 6.4  10
46 m
3  2 
10
13 AU
3  6  10
22 cubic light years) larger than the
solar system (2.7  10
5 AU
3, assuming a sphere
enclosing the planetary disc), with boundaries expand-
ing through the universe at a greater speed than the
speedoflight.Thissomewhatsillymathematicalexercise
illustrates the awesome potential of exponential growth.
Clearly, itisunsustainable, and the implications are gen-
eral. Although a 20 min doubling time is exceptionally
fast, the 3 days encompassed by this calculation are a
small part of the approximately 3.6 Gyr of life on the
Earth. Thus,the available resources,asMalthus pointed
out, will eventually limit the growth of even slowly grow-
ing organisms. Micro-organisms beneﬁt from an ability
to survive periods of limitation in quiescence if they
then can emerge from this quiescence and ﬂourish
when conditions are again favourable. This advantage
creates a powerful evolutionary drive for effective forms
of quiescence.
If quiescence appeared early in evolution, then this
capability might have been passed on and so spread
widely in phylogeny. Consistent with this, we ﬁnd well-
developednutritionalcontrolofgrowthandproliferation
in diverse organisms. Although spread of a primordial
regulatory scheme could result in a common regulatory
mechanism used throughout phylogeny, evolutionary
specialization could diversify the initial mechanism or
add new mechanisms. Indeed, diversity is evident in
the natural histories of many organisms that feature
specialized quiescent zygotes or spores that are the cen-
trepiece of varied reproductive strategies emphasizing
survival and dispersal. Apparently, quiescence has been
adapted to suit the specialized purposes of diverse
biological contexts.
3. DISTINCTIONS IN THE BIOLOGICAL PURPOSE
OF QUIESCENCE
In the earlier-mentioned discussion, I have conﬂated
two forms of quiescence having different purposes.
One type of quiescence is induced by deprivation and
it serves the purpose of aiding the survival of cells
until more opportune times. But the cells of an adult
mammal are housed in a protected nutritive environ-
ment. What is the purpose of their quiescence and
what is the inducing signal? Quiescence in the
mammal serves the purpose of the entire organism
rather than the individual cells. One purpose of quies-
cence is to arrest the growth of the organism. Stopping
growth at an appropriate adult size has been selected
because metazoans have complex body plans that func-
tion optimally at a particular size. Additionally, arrest of
proliferation has the advantage that it releases con-
straints on differentiation in that it frees cells to adopt
specializations that might impede cell division [7].
While some metazoans also exhibit a developmental
quiescence, a diapause, in response to nutritional
deprivation, I will not deal with such diapauses here.
It is not immediately apparent how distinctions in
biological purpose might impact on the mechanisms
used, except that one can assume that the inducers
of quiescence vary depending on the purpose. The
issue of the inducing mechanism is particularly mys-
terious and complex in metazoans. In an attempt to
build a foundation for comparing quiescence in
different systems, I begin with considerations of
the conditions and signals that induce quiescence
in metazoans.
4. SIZE CONTROL AND COUPLING TO
QUIESCENCE
Animals vary enormously in size [7]. Just among mam-
mals, the range is about 10
7-fold from a 15 g mouse to
a 150 tonnes blue whale. But increasing scale requires
a change in the body structure to accommodate the
fact that attributes such as weight and limb strength
do not maintain the same proportion as size
increases—weight increases in proportion to the cube
of linear dimensions, whereas limb strength increases
in proportion to the square of linear dimensions.
Thus, each body plan functions optimally only within
a limited range of sizes. Although the mammalian
embryo can grow many orders of magnitude in utero
during foetal growth, mammals in every size range
grow roughly 20-fold from birth to maturity, at which
time growth ceases [7]. From this, it appears that
physicalconstraintsdictate awidespread developmental
pattern that limits body size to a narrow range compati-
ble with function. Notably, cessation of growth of the
organism involves cessation of cellular growth and pro-
liferation.Thus,theslowingofgrowthisachievedbythe
induction of quiescence.
The control of size is one of the most mysterious
aspects of biology. Its inﬂuence is also widely under-
appreciated. Size is not only regulated at the end of
growth,butitisalsoregulatedthroughoutdevelopment.
Indeed, the shaping of organs and the organism itself is
owing to the regulation of the size of its parts. The near
perfection of bilateral symmetry highlights the accuracy
with which size regulation proportions different body
parts. Although we understand little of the mechanisms
of size regulation, increased interest and attention
have led to several new discoveries and stimulated
a number of reviews that outline the features of growth
control and identify some of the inputs [7–12]. Here,
I summarize some of the important insights, as these
impinge on our understanding of the regulation
of quiescence.
Acouplingofquiescencewiththeapproachtofullsize
can be seen in numerous systems. In mammals, there
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slows [10,13]. In Drosophila, size regulation is most
clearly evident and most thoroughly studied in the ima-
ginal discs, groups of larval cells that comprise the
anlagen of adult structures. The wing disc cells grow
and proliferate exponentially from the middle of the
ﬁrst larval instar throughout the larval period, slowing
and ultimately arresting as the disc reaches full size [14].
A number of mutations alter growth so that all body
parts increase in proportion [15,16]. This ﬁnding
suggests that there are systemic signals that regulate
the size of the organism. Indeed, endocrine factors,
such as insulin-like growth factor, have been found
to inﬂuence body size in ﬂies as well as in mammals
[10,15,17]. However, the levels of these hormones
do not decline in parallel with growth, and animals
deﬁcient in their production still exhibit size control,
albeit at a reduced size [10,15,17]. Thus, there clearly
must be other factors contributing to the onset of
growth quiescence with maturity.
Transplantation of tissues/organs in ﬂies and mam-
mals shows that organ- or tissue-autonomous signals
play an important role in size control [7–12]. For
example, in mammals, transplantation of foetal
thymus glands into an adult is followed by the
growth of the tissue to the normal full size, which is
followed by cessation of growth [11]. If the full-sized
wing disc is offered further opportunity to grow and
proliferate by delaying formation of the pupa, or by
transplanting the disc undamaged into a younger
larva, then it remains quiescent [18]. Cutting the
disc induces a regenerative response that reveals a con-
tinued capacity for growth and cell duplication [14].
Thus, the quiescence, which is induced only when
the disc reaches full size, is intrinsic to the disc and
requires that the disc remain intact. These obser-
vations show that ﬁnal size triggers cellular quiescence.
Where described, growth of a metazoan does not
progress exponentially to a sudden arrest at the size
of the mature organism, but rather shows a gradual
slowing as a juvenile approaches full size. This feature,
along with the existence of both promoters and inhi-
bitors of growth, suggests that growth is a graded
phenomenon and that it integrates many inputs.
Importantly, not all regulatory inputs that inﬂuence
ﬁnal size need change with growth. Perhaps only one
input changes as an embryo/animal grows, whether
an inhibitory input that increases with size or a
growth promoting input that decreases with size. All
the other inputs might be more or less constant or
carry information about parameters other than size
(e.g. nutrition) and could adjust the size threshold at
which the balance of signals no longer promotes
growth. Based on the autonomy of growth control
in tissues and mutations that cause overgrowth in
Drosophila, I suggest that tissue/organ-autonomous sig-
nals produce a growth inhibitory input that increases
in magnitude as size increases [14,19]. Accordingly,
systemic growth signals would operate on all tissues,
and growth of each tissue would stall when it reached
a size where the integrated inputs of local and systemic
signals no longer promote growth. Such a model could
account for the various nutritional and environmental
inputs into growth and overall size [10,20,21]. It also
argues that numerous signals are likely to be integrated
by the circuits that regulate quiescence.
5. DIVERSE TISSUE-SPECIFIC PROGRAMMES
OF GROWTH CONTROL
Growth and development proceed differently in dif-
ferent tissues. We can identify at least three general
types of regulatory programmes. In one type of regu-
lation, exempliﬁed by tissues such as the ﬂy discs
and the mammalian liver, growth and proliferation
are widespread, occurring throughout the tissue.
This dispersed growth and proliferation slows to
almost a complete stop at the growth limit. In a
second pattern of growth and proliferation, there are
specialized proliferative cells that can be concentrated
in growth zones (e.g. the epiphyseal plates of bone)
or dispersed throughout the tissue (e.g. the satellite
cells of muscle). In a third pattern of growth and pro-
liferation, every division appears to be developmentally
programmed according to an exact schedule dictated
by other events in development. Furthermore, as
detailed below, individual tissues practising each of
these styles of regulation can exhibit additional
distinctions in their regulation of quiescence.
Tissues that exhibit widespread proliferation prior to
quiescence (the ﬁrst pattern of growth and proliferation)
can arrest in different ways. For example, the arrest of
larval proliferation in the Drosophila eye disc is associated
with a specialized morphogenetic wave of differentiation
that traverses the eye, whereas the cells of the wing disc,
with the exception of a minor population of early arrest-
ing cells at the wing margin, behave relatively uniformly
and gradually extend their cell cycle [14,22–25].
In tissues with specialized generative or stem cell
populations (the second pattern of growth and pro-
liferation), differentiation is associated with an exit
from the cell cycle. This type of control of growth
and proliferation is associated with multiple kinds of
quiescence—the differentiating population of cells
ceases proliferating (proliferation quiescence) but the
differentiated cells can continue to grow in size until
a separate onset of growth quiescence. Furthermore,
the quiescence of the generative cells themselves is
distinctly regulated.
Unlike the quiescence of tissues such as liver or the
discs of the Drosophila larva, the timing of proliferation
quiescence in systems with a specialized generative
population of cells is coupled to differentiation and not
closely coupled to attainment of ﬁnal size. Differen-
tiation-associated quiescence accompanies some of the
ﬁrst events of tissue differentiation in development and
continues into adulthood where stem cells continue to
replace particular tissues that turnover (e.g. skin), and
where stem cells can be reactivated during the repair
after wounding or injury.
The proliferation quiescence of differentiated cells
is not necessarily associated with quiescence in cellular
growth. For example, neurons often grow immensely.
Following its formation in the embryo, the axon of a
motor neuron innervating the leg of a giraffe will grow
from micrometres to metres and do so in coordination
with organismal growth. Thus, differentiation
quiescencediffersfromgrowthquiescenceinitsfeatures
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siders the growth of a neuron, for example, it appears
that in addition to the proliferation quiescence that is
engaged when it ﬁrst embarks on the pathway to differ-
entiation, there has to be a second type of regulation
that modulates growth, which ultimately leads to
growth quiescence at maturity.
In addition to a proliferation quiescence and a
growth quiescence associated with the differentiating
cells, tissues with a generative population can exhibit
one more type of quiescence—quiescence of the stem
cells whose activity is an important driver of the
growth. For example, overall stature is largely the
result of the growth of long bones in juveniles. This
growth is driven by the activity of the epiphyseal
plate, a generative layer that deposits cartilage that is
ossiﬁed as it is displaced from the plate. The epiphy-
seal plate matures and loses activity at puberty. Like
the growth of the liver and the growth of the already
formed axons, the activity of the epiphyseal plate is
coupled to size and maturity. But as noted already,
the activity of generative cells, such as the basal cells
in the skin, crypt cells in the gut and glial stem cells,
is not coupled to organismal size. Distinct develop-
mental inputs appear to coordinate the activity of
different stem cell populations.
The third style of growth and proliferation is highly
regimented. For example, the proliferation that gives
rise to the soma of the Caenorhabditis elegans worm fol-
lows an almost invariant lineage, and the few examples
of a probabilistic cell fate speciﬁcation appear to be
genetically programmed switches. The early ﬂy
embryo has only slightly less rigidly stereotyped div-
isions. In the ﬂy embryo, 13 synchronous cell cycles
are followed by three cell cycles that follow position-
dependent schedules. Almost all cells exit the mitotic
cell cycle in cycle 16. Even though there is no precise
lineage of the divisions within stereotyped territories,
the division domains [26], the number and time of
the all the divisions are speciﬁed by inputs from the
patterning genes guiding early development. The
spatially programmed divisions are limited by the
availability of the mitotic phosphatase Cdc25 encoded
by string, whose transcription is dependent on develop-
mental regulators known to govern the morphological
pattern of the embryo [8,27,28]. These developmental
regulators are transcription factors or the regulators of
transcription factors, and they are expressed in spatial
and temporal patterns in the embryo. Like coordinates
for latitude and longitude, combinations of these devel-
opmental regulators can specify position. Additionally,
the levelsof the regulators reﬂect time. Acting in combi-
nations, they promote Cdc25 expression according to a
spatial and temporal schedule that then drives the
patterned mitoses [8]. These examples show that at
times, developmental control acts as an exacting
master continuously dictating the precise schedule of
cell cycle progression. In such a context, these rigid
developmental programmes also regulate the onset of
quiescence (see later text).
These brief considerations of quiescence in metazo-
ans emphasize its connection to development and
introduce the notion that there are diverse forms of
quiescence. The diverse manner in which quiescence
is coupled to growth in different tissues and organs
suggests that evolution has engaged varied types of
tissue-speciﬁc developmental programmes to regulate
quiescence.
6. FROM WHENCE THE DIVERSITY
Earlyevolution of quiescence and itswidespread associ-
ation with maturation in metazoans educe thoughts of
universality, but the inputs into quiescence in metazo-
ans display a bewildering diversity that challenges our
ability to see generalities. With the exception of a
few groupings of tissues with parallel developmental
courses, patterns of growth and proliferation are
remarkably tissue-speciﬁc. Despite the complexity,
there is a gratifying appropriateness to the diversity, as
the details of the growth programme for each tissue
are beautifully tailored to the speciﬁc structures being
produced. Indeed, it is what one expects for a process
regulated as part of the developmental programme.
Evolution has produced extraordinarily diverse body
shapes and sizes. This can be understood in part as the
result of the fact that natural selection acts largely on
the structure and performance of an organism’s body.
However, the rapid diversiﬁcation requires plasticity in
the mechanisms governing shape and size. A precedent
suggests an origin of the plasticity. Upon recognizing
that the development of each segment of the insect
body plan can be distinct from any other segment
because of the action of particular homeotic genes,
E. B. Lewis suggested that the independence allowed
each segment to be a separate experiment in evol-
ution—that is, variants could affect the pattern of only
one segment and those changes that were advantageous
could be selected without compromising the develop-
ment of the remaining segments [7,29]. Similarly,
autonomous and distinct control of the size of
individual body parts allows evolution to modify body
structure by changes in the relative size of different
parts—examples of which are the elephant’s trunk, the
giraffe’s neck and the butterﬂy’s wings.
It is clear that not everyexample of diversity in devel-
opmentalprogrammingmarksadiversityofmechanistic
inputs. The same regulators can be used in different
developmental contexts. For example, the halteres of
Drosophila are small vestigial wing-like structures on
the third thoracic segment that can be transformed
into wings if they lose the expression of the homeotic
gene, Ubx. Ubx inﬂuences the size of these structures
by altering the gradients of two morphogens, Wingless
and Dpp (BMP homolog), whose expression in source
cells is directed by Notch and Hedgehog, respectively
[9]. More impressively, the same regulators can be
used in structures that are not analogous and that use
dissimilar morphogenetic processes. For example, the
important signalling molecules Hedgehog, Wingless,
Dpp and Notch are central players in controlling
g r o w t ha n dp r o l i f e r a t i o ni nb o t ht h ew i n gd i s ca n de y e
disc, in which there is no obvious parallel between the
programmes of cell cycle and growth arrest [14,30–33].
Apparently, changes in where and when they and their
collaborating regulators are produced allow these
conserved regulators to function as pivotal determinants
of dissimilar programmes.
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ﬁcity of programming in different tissues within the
organism and suggests that this is because growth, pro-
liferation and quiescence are inherent components of
the developmental programme.
7. QUIESCENCE OF WHAT?
Much of the literature on quiescence discusses the
problem as one of how cells exit the cell cycle. As
cells exit the cell cycle during quiescence, this is
indeed part of the problem, but often quiescence
involves more than this exit. To survive nutritional
quiescence, micro-organisms usually induce a meta-
bolic quiescence. Furthermore, nutritional limitation
forces a growth quiescence (conservation of mass),
and growth quiescence is an intrinsic part of size con-
trol in metazoans. How are these different aspects of
quiescence related? They appear to form a causal
hierarchy where metabolic quiescence can cause
growth quiescence, and growth quiescence can cause
cell cycle quiescence, but not the other way around.
The causal hierarchy should be recognized in consid-
ering the mechanisms that cause quiescence.
Mass increase (growth) and cell number increase
(proliferation) go hand-in-hand during the exponential
growth of yeast culture or other cultured cells, and,
among vertebrates, the bigger species have correspond-
ingly more cells [11]. This has caused investigators to
equate growth and proliferation. However, the coupling
of growth and proliferation is frequently broken [7,34],
and where it does exist, it is of interest to know whether
the coupling is achieved because the cell cycle regulates
growth, or growth regulates the cell cycle [34]. In an
exponentially growing population of cells, mutations
that speciﬁcally block cell cycle progress do not block
continued increase in cell mass (although the rate of
mass increase eventually switches from exponential to
linear [35–37]). Reciprocally, when growth is arrested,
usually by nutrient limitation, most cells arrest pro-
liferation within one cell cycle of the arrest of growth
[35–37]. Studies of this arrest suggest that cells have a
size threshold below which they arrest cell cycle pro-
gress, usually in G1/G0 [35–37]. This size threshold
imposes a unidirectional coupling of growth and
cell cycle in which growth quiescence can enforce
proliferation quiescence but not vice versa.
Considerations of the biology of growth and pro-
liferation in metazoans also argue that cell cycle
arrest is not sufﬁcient for growth quiescence. This is
apparent from the natural histories of many organisms,
perhaps most notably the nematodes. The free-living
nematode, C. elegans, grows to about 1 mm in
length, whereas its parasitic cousins, such as Ascaris,
reach about 400 times this length (about 10
7 times
the mass, roughly the magnitude of the fold difference
between the size of a mouse and blue whale [7]).
Despite the difference in size, Ascaris has the same
anatomy and the same number of cells as the diminu-
tive C. elegans. The size difference is achieved by
continued postmitotic growth in Ascaris, illustrating
that an arrest of cell proliferation does not terminate
the growth phase. Experimental manipulation of the
cell cycle in Drosophila demonstrated that cell cycle
quiescence does not block growth [35–38]. For
example, in proliferating imaginal disc cells, clonal loss
of function of the essential cell cycle gene string, which
encodesCdc25,producedarrestedcellsthatgrewexces-
sively large [35–37]. Thus, like the study of cultured
cells, these analyses suggest that cell cycle quiescence
is not sufﬁcient to achieve growth quiescence.
Although less attention has been paid to the connec-
tion between metabolic quiescence and growth
quiescence, growth is a major energy-consuming activity
that cannot be maintained without metabolic activity,
both anabolic activity to provide the material for growth
and catabolic energy production to drive the process.
But the opposite is not true. Growth quiescence does
not cause metabolic quiescence. Two examples illustrate
this. First, starvation of E. coli for glucose can stall
growth, but it also induces the ﬂagellar apparatus and
active swimming. Second, the adult mammalian brain
has ceased growing, yet is the seat of intense metabolic
activity. Generally, unicellular organisms include meta-
bolic quiescence as part of their response to nutritional
deprivation, but in metazoans the onset of growth and
cell cycle quiescence at maturity is usually not coupled
to metabolic quiescence.
The consequence of the hierarchy in the regulation
of different forms of quiescence is that different mech-
anisms give different forms of quiescence. Inhibition of
cell cycle regulators sufﬁces to give cell cycle quies-
cence but not growth quiescence, whereas inhibition
of growth can give both cell cycle and growth quies-
cence. At ﬁrst glance, the hierarchy suggests that one
should not have situations in which growth is blocked
but cells continue to divide. However, this can arise
because a cell, such as an oocyte, that grows larger
than the minimum threshold required for division
can support continued divisions without growth until
the size of the daughter cells drops below the size
threshold for cell cycle progression. Finally, if meta-
bolic quiescence were induced, then both growth and
cell cycle quiescence would follow by indirect control.
8. DEVELOPMENTAL PROGRAMMES
OF QUIESCENCE
I am interested in focusing the present discussion on
quiescence in the organism, as opposed to tissue cul-
ture models, because I believe that the latter give a
distorted view of the relevant and predominant con-
trols. Here, we focus on growth and proliferation,
emphasizing a few examples from Drosophila in which
genetic dissection deﬁnes the inputs.
Following fertilization and 13 extremely rapid and
synchronous mitotic cycles that lack a G1 or G2
phase, a G2 phase is introduced in cell cycle 14.
This pause in the cell cycle is created by elimination
of maternally supplied mitotic activator, Cdc25 phos-
phatase, that removes inhibitory phosphates from
cyclin:Cdk1 complexes. Most of the cells of the
embryo only pause in cycle 14, because new
expression of Cdc25 will drive cells into mitosis after
a time delay that is proscribed by the position-speciﬁc
cascade of developmental regulators [28,39]. How-
ever, a dorsally located tissue called the amnioserosa
never re-expresses Cdc25 and never divides again.
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expressed during the G2 arrest, then the amnioserosa
cells will be induced to divide [40]. As the embryo
ages, the amnioserosa cells adopt a distinctive mor-
phology, and become somewhat less responsive to
Cdc25, but it is nonetheless clear that Cdc25 is
initially the factor that limits the progress of the cell
cycle [27,40]. Mutations affecting patterning of the
embryo cause Cdc25 to be expressed in the region of
the amnioserosa and lead to division [41]. Hence,
these cells, which represent the earliest quiescent
cells of embryogenesis, are arrested in G2 of cell
cycle 14 because they lack Cdc25.
Most of the cells of the Drosophila embryo progress
beyond cycle 14, and execute three more divisions that
are driven by periodic pulses of Cdc25 gene
expression. After mitosis 16, most of the cells pause
in the ﬁrst G1 phase [27,42,43]. Cell cycle regulation
is substantially restructured to introduce this G1
quiescence in cycle 17. The expression of several cell
cycle regulators changes during cycle 16, and three
of the changes are required for the appearance of a
G1 phase following mitosis 16: cyclin E expression is
shut-off; expression of a cyclin E inhibitor, Dacapo,
is activated; and an activator of the anaphase promot-
ing complex (APC), Fizzy-related (Fzr), is expressed
[42,44,45]. Shut-off of new cyclin E expression as
well as Dacapo inhibition of persisting cyclin E :
Cdk2 reduces this G1 cyclin function to levels below
those required to initiate S phase following mitosis
16 [42,44–46]. Additionally, the expression of Fzr (a
Cdh1 homolog) maintains the activity of the APC to
promote postmitotic destruction of mitotic cyclin
Cdk [45], which otherwise has a capacity to drive S
phase [42,47]. In addition to these changes in gene
expression, two other factors contribute to the emer-
gence of G1 quiescence. E2F1, which was previously
stable, is degraded during S phases 15 and 16, and
its absence was shown to be important because induc-
tion of E2F1/Dp1 triggers S phase shortly after mitosis
16 [48,49]. The Drosophila retinoblastoma gene pro-
duct, Rbf1, also plays a role in stabilizing the G1
following mitosis 16. If both maternal and zygotic
sources of Rbf1 are eliminated, then mutant embryos
exhibit ectopic E2F-dependent gene expression and
S phase 17 after a transient G1 [50]. In addition to
these genes, whose function inﬂuences the appearance
or the stability of the G1, cycle 16 cells exhibit
additional changes in cell cycle regulators such as an
extinction of the expression of cyclin A, cyclin B and
Cdk1 [51,52]. Altogether, these changes reveal a
large-scale reconﬁguration of cell cycle regulation in
association with the introduction of G1 quiescence in
cycle 17. Importantly, the changes in expression of var-
iouscellfactorsoccur inaspatiallyprogrammedfashion
and they continue even in an embryo whose cell cycle is
arrested [42,43]. Thus, the changes that introduce G1
quiescence are programmed by developmental signals
independent of the progress of the cell cycle.
The future fates of cells that arrest in G1 of cycle 17
during embryogenesis are varied. Most of the cells will
never divide again, but will grow, enter programmed
cycles of endoreduplication and will build the various
larval tissues. Others will remain quiescent through
the remainder of embryogenesis, re-enter the cell
cycle during the ﬁrst larval stage and will develop
into the various discs. Here, I would like to highlight
the fate of histoblasts, which ultimately form the
epidermis of the adult abdomen.
Small clusters of histoblast cells are speciﬁed in each
embryonic abdominal segment primordium. These
enter proliferation quiescence after the 16 embryonic
cycles, as mentioned already, and remain quiescent
for the next few days, throughout the remainder of
embryogenesis and all of larval growth. Although
initially arrested in G1 of cycle 17, the histoblasts repli-
cate their DNA and by early larval stages are in G2,
where they remain arrested owing to failure to express
Cdc25 [53]. Although in cell cycle quiescence, the his-
toblasts continue to grow during the long G2 arrest and
they also accumulate cyclin E and probably other com-
ponents required to advance cells from G1 into S phase
[53]. Thus, at the end of the larval period, these cells
are large and primed to proliferate, save for the lack
of Cdc25. After pre-pupa formation, a rise in the ecdys-
terol hormone induces the expression of Cdc25 and
activates a series of three rapid cell cycles (2.5 h) that
lack a G1 phase. During these rapid cycles, the large
histoblasts are reduced in size. These rapid cycles are
followed by slower cycles (5–8 h doubling time) that
are growth factor (Spitz and epidermal growth factor
receptor) dependent. These cycles have a G1 phase,
and cell duplication is accompanied by a doubling of
cell mass so that cell size then remains constant. The
insulin receptor and phosphatidyl inositol 3-kinase
signalling are required for the growth of the histoblasts
during these later divisions, and mutants in these path-
ways lead to an arrest of proliferation with small cells.
The rapid proliferation of the histoblasts produces a
population of cells which will form the abdominal
epithelium of the adult. This example provides a nice
case study that illustrates how a variety of controls can
be brought into play to manipulate growth, proliferation
and quiescence [53].
Analyses of proliferation histories of different tissues
of the ﬂy, while uncovering considerable diversity, also
suggest some generalities. In contrast to views of the
cell cycle as an autonomous oscillating system, at
times cell cycle mechanisms abdicate responsibility
for timing cell cycle progress to developmental cues
that control expression of a cell cycle regulator (e.g.
Cdc25) to dictate where and when cells will transit a
step of the cell cycle [8]. Furthermore, even when con-
sidering the same population of cells, the mode of cell
cycle regulation can change dramatically from one
stage to another. In the example of the histoblasts,
we have seen cycles controlled at the G2–M transition,
cycles controlled at G1–S, cycles in which growth
does not accompany division, cycles where growth
and division are coupled, and we have seen that differ-
ent cell regulators can act as the pivotal determinants
of cell quiescence. Despite the intricate programmes
of proliferation control, commonalities suggest that a
limited number of pathways are deployed in various
combinations to produce the varied programmes.
Hopefully, we can identify the fundamental control cir-
cuits without losing sight of the how these programmes
are deployed in vivo.
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REGULATORS OF QUIESCENCE?
Cancer biology has proved to be a powerful context to
identify mutations that disrupt quiescence and give
rise to uncontrolled growth in humans, but the paral-
lels are not simple. Activation of quiescent cells is
only one of the changes required for sustained patho-
logical growth [54], and even this one step appears
extremely complex. Nonetheless, some tumour sup-
pressor genes have pivotal roles in suppressing
proliferation or growth. However, studies of the roles
of these genes in normal biology have not really
shown that these genes are essential for cellular quies-
cence, but this appears to be the consequence of
inﬂated expectations rather than a lack of contribution
to quiescence.
The retinoblastoma gene (Rb), the archetype of the
tumour suppressor class of genes, has characteristics of
a pivotal regulator of quiescence [55]. Rb and its rela-
tives, the pocket proteins, interact with the key
transcription factor, E2F, converting it from an activa-
tor of S phase genes to a suppressor of S phase genes.
Distant relatives of Rb are found in organisms from
yeast to humans, and in these organisms Rb has a simi-
lar interaction with a key S phase transcription factor
[50,56,57]. Thus, Rb is a central and conserved regu-
lator of cell cycle quiescence, and loss of this
regulatory pathway appears to make a key contribution
to the ‘success’ (rampant growth) of tumours. This has
attracted a great deal of attention to the pathways that
drive the dissociation of Rb from E2F, which are pre-
sented as fundamental to the control of cell cycle
progress. Accordingly, a G1 cyclin:Cdk complex
(cyclin D:Cdk4 or cyclin D:Cdk6) phosphorylates
Rb, promotes its dissociation from E2F and activates
expression of S phase functions particularly cyclin E.
Cyclin E then functions in conjunction with Cdk2 to
promote the S phase. While the steps described have
been extensively documented, an analysis of in vivo
phenotypes of mutations that disrupt these steps in
mice, ﬂies and worms suggests that this regulatory
scheme is not globally required.
Knockout of Rb in mouse is lethal, but the
homozygous embryo reaches foetal stages with a well-
established body plan and differentiated tissues
[58–60]. Additionally, if a chimera containing a mix of
Rb mutant and normal cells is made, then the mouse is
viable and Rb mutant cells contribute widely to the
tissues of the adult [61]. These ﬁndings show that devel-
opment, differentiation and stable quiescence occur in
the absence of Rb function despite its proposed role in
the fundamental regulatory switch stalling cells in G1.
One simple possible explanation for the dispensa-
bility of Rb is that related regulators, the ‘pocket
proteins’, might substitute for it. In this case, one
would expect that G1–S regulation would still be
intact in the Rb mutant. Signiﬁcantly, an analysis of
Rb mutant cells in brains of chimeric mice revealed
that these cells had 4N DNA content [62]. This ﬁnd-
ing implies that the Rb mutation did disrupt the
normal restriction in the progression of the cell cycle
from G1 to S phase, but the cells nevertheless success-
fully differentiated as neurons and remained quiescent,
but now quiescent in G2. Thus, the lack of a
quiescence phenotype is not owing to redundant activi-
ties (e.g. the related pocket proteins) ﬁlling in for Rb,
but rather appears to be owing to the action of alterna-
tive pathways that can mediate quiescence, at least in
the affected neurons of the brain, despite the disruption
of the Rb/E2F switch. Studies in model organisms
support the idea of redundant pathways contributing
to quiescence.
Studies of growth control in proliferating cells of the
wing disc reveal a remarkable ﬂexibility in the regulat-
ory inputs into cell cycle progression and growth.
Neufeld et al.[ 36] induced recombination that gave
rise to clones of cells with altered activity of various
cell cycle regulators within the wing disc epithelium.
If they over-expressed the Cdc25 phosphatase encoded
by the string gene in these clones, then G2 was shor-
tened, but there was a compensatory increase in G1,
and cell size remained roughly constant with the over-
all expansion of the clone (area occupied by the
progeny cells) remaining unchanged. Reciprocally,
shortening of G1 caused by increased expression of
cyclin E resulted in a prolonged G2 and gave little
change in growth. Disruption of the Rbf/E2F regu-
lation affected both G1 and G2 regulation, but its
consequences were still buffered by other controls.
For example, over-expression of both subunits of
the E2F transcription factor E2f1/Dp promoted the
expression of both cyclin E and Cdc25; in the presence
of an apoptosis inhibitor, this treatment promoted pro-
liferation of the cells. However, the cells did not exhibit
unregulated growth. The individual cells were smaller
and overall expansion of the clone was unchanged.
Reciprocally, over-expression of Rbf1 slowed prolifer-
ation of the cells, but now the cells were bigger and
again there was little inﬂuence on the expansion of
the clone. Apparently, growth control was not dis-
rupted by changes in the cell cycle and this growth
control had a homeostatic inﬂuence on the size of
the clone; the cells comprising these clones ultimately
entered quiescence after making an appropriate contri-
bution to overall tissue growth. These ﬁndings show
that even in a context in which the Rb pathway inﬂu-
ences cell cycle progress, there are other pathways
that have an impact on growth and eventually arrest
proliferation of the cells.
As described already, wing disc cells arrest prolifer-
ation at least transiently once the disc reaches full size.
The majority of the cells are arrested in G2 during this
stage [22] in a Cdc25 limited state [63]. The cells
remain arrested in G2 for about 12 h after initiation
of the formation of the pupa and the beginning of
wing morphogenesis. Then most cells go through
two mitoses as they differentiate and arrest perma-
nently in G1 about 12 h later [23,24]. In an effort to
determine the role of Rb and associated regulators in
this ﬁnal quiescence, clones of cells were induced in
which different cell cycle regulators were inactivated
or over-expressed during the pupal stages [64,65].
The results suggested a progressive increase in the
stability of quiescence in that several perturbations
that inactivate Rb and/or activate E2F were able to
extend cell cycle activity for one more cycle, but no
more than one cycle. However, if measures were
taken to deregulate additional steps, then cell cycles
3504 P. H. O’Farrell Review. Quiescence
Phil. Trans. R. Soc. B (2011)could be maintained through later stages. For
example, over-expression of cyclin E and Cdc25
within a clone of cells lacking Rbf1 induced extensive
additional cycles and overgrowth [64,65]. These ﬁnd-
ings suggest that the initial arrest of the cells in their
terminal G1 phase relies on the Rb/E2F pathway,
but that several barriers to proliferation arise as the
developmental programme progresses.
The diverse programmes of control exhibited at
different times and in different tissues create situations
in which particular tumour suppressors can be crucial
to the regulation of proliferation during distinct win-
dows of time in particular lineages, whereas at other
stages different pathways take regulatory responsibility.
A recent study of the development of the optic lobe of
Drosophila from a neuroepithelium provides a nice
example of this [66]. The slowing of proliferation in
the neuroepithelium precedes differentiation into neu-
roblasts, which then exhibit a distinct programme of
divisions. The Hippo pathway is required to constrain
proliferation in the neuroepithelium and for the devel-
opmental transition to neuroblasts. At this stage,
activation of Yorkie, the transcription factor suppressed
by the Hippo pathway, drives massive overgrowth.
Apparently, this transformation-like phenotype results
from the combined abilities of Yorkie activity to block
the differentiation of the neuroepithelial cells and to
drivetheproliferationofthesecells.Afterdifferentiation
of the neuroepithelial cells into neuroblasts, the Hippo
pathway is no longer required to suppress growth.
EvenfullactivationofYorkiedoesnotdriveproliferation
subsequent to neuroblast differentiation.
These in vivo analyses show that tumour suppressor
genes make important, conserved and widespread
contributions to cellular quiescence. However, they
also illustrate the signiﬁcance of backup and alterna-
tive modes of regulation that can cover for the loss of
a tumour suppressor function at different times and
places. In the context of these overlapping regulatory
inputs into quiescence, it is not surprising that the
consequences of tumour suppressor mutations are
markedly tissue-speciﬁc.
10. THE CONCEPT OF GROWTH FACTORS AS
SURROGATES FOR NUTRIENTS
The discussion has emphasized the fact that cellular
quiescence in metazoans is developmentally pro-
grammed, and connected to size control. Yet, no
matter the complexity of the developmental inputs
and multiple modes of cell cycle arrest, some com-
monalities exist in the cellular changes associated
with the transition from active growth to quiescence.
The most obvious common point is that actively grow-
ing cells make an abundance of the components that
are needed for growth, and in widely diverse species
the machinery for protein synthesis is one of the key
contributors to growth [67–69]. As down-regulation
of growth genes is common to the transition to quies-
cence, we might expect conservation of the cellular
pathways underlying quiescence. However, an encom-
passing synthesis would have to account for the
distinctions in the types of regulatory inputs in
single-cell organisms and in metazoans.
Single-cell organisms respond to nutrient limitation
with cell cycle quiescence, and often it is the nutrients
themselves that provide the signal to enter quiescence.
In contrast, in the more complex metazoans, homeo-
static physiological controls provide cells with a
consistently nutritive environment, and cells enter
quiescence for other purposes as discussed already.
Instead of nutrients, growth factors and cytokines pro-
vide the key regulatory inputs. This change might be
made while preserving the cellular signalling mechan-
isms if the cellular pathways governing quiescence
just switch their inputs. Thus, while a single-celled
predecessor of metazoans might have sensed many
nutritional signals to properly adjust its growth rate,
a metazoan might sense growth factors and cytokines,
each of which functions as a surrogate of a nutrient.
The concept of growth factors as surrogates of nutri-
ents opens up the possibility that mechanisms of
quiescence used in single-cell model organisms might
be relevant to mammals. However, the concept is not
as unifying as one might think. Even when evolution
conservesregulatorylogic,thecircuitryoftheregulation
can differ [70,71], and clearly there have been changes
in the cellular pathways that regulate the expression of
the protein synthesis machinery. For example, ppGpp
(magic spot), which is used as a specialized regulator
of ribosomal RNA synthesis and activity of the transla-
tional apparatus in E. coli [72–74], has diverse uses
among prokaryotes and is not found in eukaryotes
[74]. Additionally, the regulators of growth genes in
Saccharomyces cerevisiae are not conserved even among
yeasts [71]. Of the various cellular regulators of
growth, the target of rapamycin (TOR) pathway is per-
haps the most conserved, at least in the sense that the
TOR kinase appears to have important inputs into
growth in S. cerevisiae, Drosophila and mammals, and
the immediate regulators upstream and downstream of
TOR regulation are conserved. However, the TOR
regulatory moduleappearstobe used in growth regulat-
ory circuits that have diverged signiﬁcantly. For
instance, comparison of nutrient regulation of TOR in
S. cerevisiae with growth factor inputs in ﬂies and mam-
mals shows differences well beyond a simple
substitution where a growth factor plays a role analo-
gous to the nutrients. The major inputs into the TOR
pathway in metazoans are mediated by tyrosine kinase
receptors, a class of proteins not found in yeast. Thus,
major modiﬁcations of signal transduction distinguish
the upstream and downstream steps in the action of
TOR in growth control.
In summary, the biology of quiescence reveals diverse
regulatory inputs. There are notable parallels in the regu-
lation of quiescence between Drosophila and mammals.
However, within both mammals and ﬂies there are
diverse modes of regulating quiescence. The parallels
suggest that a plurality of mechanisms may be conserved
among metazoans, but it remains to be seen whether the
manner of deployment of these various mechanisms is
also conserved. When one looks beyond metazoans,
there are examples of regulatory diversiﬁcation indicating
that pathways regulating quiescence have been
profoundly modiﬁed during evolution.
Funding was provided by NIH 2R37GM037193.
Review. Quiescence P. H. O’Farrell 3505
Phil. Trans. R. Soc. B (2011)REFERENCES
1 Dennis, P. P. & Bremer, H. 1974 Macromolecular
composition during steady-state growth of Escherichia
coli B/r. J. Bacteriol. 119, 270–281.
2 Harding, J. D., MacDonald, R. J., Przybyla, A. E.,
Chirgwin,J.M.,Pictet,R.L.&Rutter,W.J.1977Changes
inthefrequencyofspeciﬁctranscriptsduringdevelopment
of the pancreas. J. Biol. Chem. 252, 7391–7397.
3 Ivarie, R. D., Schacter, B. S. & O’Farrell, P. H. 1983 The
level of expression of the rat growth hormone gene in
liver tumor cells is at least eight orders of magnitude
less than that in anterior pituitary cells. Mol. Cell Biol.
3, 1460–1467.
4 Malthus, T. R. 1872 An essay on the principle of population,
7th edn. London, UK: Reeves and Turner.
5 O’Farrell, P. H. 2001 Triggering the all-or-nothing
switch into mitosis. Trends Cell Biol. 11, 512–519.
(doi:10.1016/S0962-8924(01)02142-0)
6 Ingraham, J. L., Maaloe, O. & Neidhardt, F. C. 1983
Growth of the bacterial cell. Sunderland, MA: Sinauer
Associates, Inc.
7 O’Farrell, P. H. 2004 How metazoans reach their
full size: the natural history of bigness. In Cell growth:
control of cell size (CSH Monograph vol. 42) (eds M.
Hall & M. Raff & G. Thoomas), pp. 1–22. Woodbury,
NY: Cold Spring Harbor Press.
8 Follette, P. J. & O’Farrell, P. H. 1997 Connecting cell
behavior to patterning: lessons from the cell cycle. Cell
88, 309–314. (doi:10.1016/S0092-8674(00)81869-3)
9 Crickmore, M. A. & Mann, R. S. 2008 The control of
size in animals: insights from selector genes. Bioessays
30, 843–853. (doi:10.1002/bies.20806)
10 Lui, J. C. & Baron, J. 2011 Mechanisms limiting body
growth in mammals. Endocr. Rev. 32, 422–440.
(doi:10.1210/er.2011-0001)
11 Conlon, I. & Raff, M. 1999 Size control in animal
development. Cell 96, 235–244. (doi:10.1016/S0092-
8674(00)80563-2)
12 Badouel, C., Garg, A. & McNeill, H. 2009 Herding
hippos: regulating growth in ﬂies and man. Curr. Opin.
Cell Biol. 21, 837–843. (doi:10.1016/j.ceb.2009.09.010)
13 Bertalanffy, L. 1949 Problems of organic growth. Nature
163, 156–158. (doi:10.1038/163156a0)
14 Serrano, N. & O’Farrell, P. H. 1997 Limb morphogenesis:
connections between patterning and growth. Curr. Biol. 7,
R186–R195. (doi:10.1016/S0960-9822(97) 70085-X)
15 Oldham, S. & Hafen, E. 2003 Insulin/IGF and target of
rapamycin signaling: a TOR de force in growth control.
Trends Cell Biol. 13, 79–85. (doi:10.1016/S0962-
8924(02)00042-9)
16 Sutter, N. B. et al. 2007 A single IGF1 allele is a major
determinant of small size in dogs. Science 316,
112–115. (doi:10.1126/science.1137045)
17 Edgar, B. A. 2006 How ﬂies get their size: genetics meets
physiology? Nat. Rev. Genet. 7, 907–916. (doi:10.1038/
nrg1989)
18 O’Brochta, D. A. & Bryant, P. J. 1987 Distribution of
S-phase cells during the regeneration of Drosophila imagi-
nal wing discs. Dev. Biol. 119, 137–142. (doi:10.1016/
0012-1606(87)90215-6)
19 Watson, K. L., Justice, R. W. & Bryant, P. J. 1994
Drosophila in cancer research: the ﬁrst ﬁfty tumor
suppressor genes. J. Cell Sci. Suppl. 18, 19–33.
20 Osborne, T. B. & Mendel, L. B. 1916 Acceleration of
growth after retardation. Am. J. Physiol. 40, 16–20.
21 Boersma, B. & Wit, J. M. 1997 Catch-up growth. Endocr.
Rev. 18, 646–661. (doi:10.1210/er.18.5.646)
22 Graves, B. J. & Schubiger, G. 1982 Cell cycle changes
during growth and differentiation of imaginal leg discs
in Drosophila melanogaster. Dev. Biol. 93, 104–110.
(doi:10.1016/0012-1606(82)90243-3)
23 Schubiger, M. & Palka, J. 1987 Changing spatial patterns
of DNA replication in the developing wing of
Drosophila. Dev. Biol. 123, 145–153. (doi:10.1016/
0012-1606(87)90436-2)
24 Mila ´n, M., Campuzano, S. & Garcı ´a-Bellido, A. 1996
Cell cycling and patterned cell proliferation in the wing
primordium of Drosophila. Proc. Natl Acad. Sci. USA
93, 640–645. (doi:10.1073/pnas.93.2.640)
25 Crack, D., Secombe, J., Coombe, M., Brumby, A., Saint,
R. & Richardson, H. 2002 Analysis of Drosophila cyclin
EI and II function during development: identiﬁcation
of an inhibitory zone within the morphogenetic furrow
of the eye imaginal disc that blocks the function of
cyclin EI but not cyclin EII. Dev. Biol. 241, 157–171.
(doi:10.1006/dbio.2001.0496)
26 Foe, V. E. 1989 Mitotic domains reveal early commitment
of cells in Drosophila embryos. Development 107,1–2 2 .
27 Edgar, B. A. & O’Farrell, P. H. 1990 The three postblas-
toderm cell cycles of Drosophila embryogenesis are
regulated in G2 by string. Cell 62, 469–480. (doi:10.
1016/0092-8674(90)90012-4)
28 Edgar, B. A., Lehman, D. A. & O’Farrell, P. H. 1994
Transcriptional regulation of string (cdc25): a link
between developmental programming and the cell
cycle. Development 120, 3131–3143.
29 Lewis, E. B. 1978 A gene complex controlling segmenta-
tion in Drosophila. Nature 276, 565–570. (doi:10.1038/
276565a0)
30 Firth, L. C., Bhattacharya, A. & Baker, N. E. 2010 Cell
cycle arrest by a gradient of Dpp signaling during
Drosophila eye development. BMC Dev. Biol. 10, 28.
(doi:10.1186/1471-213X-10-28)
31 Chanut, F. & Heberlein, U. 1997 Role of decapentaple-
gic in initiation and progression of the morphogenetic
furrow in the developing Drosophila retina. Development
124, 559–567.
32 Burke, R. & Basler, K. 1997 Hedgehog signaling in
Drosophila eye and limb development: conserved machin-
ery, divergent roles? Curr. Opin. Neurobiol. 7, 55–61.
(doi:10.1016/S0959-4388(97)80120-1)
33 Kumar, J. P. & Moses, K. 2001 The EGF receptor and
notch signaling pathways control the initiation of the
morphogenetic furrow during Drosophila eye develop-
ment. Development 128, 2689–2697.
34 Su, T. T. & O’Farrell, P. H. 1998 Size control: cell
proliferation does not equal growth. Curr. Biol. 8,
R687–R689. (doi:10.1016/S0960-9822(98)70436-1)
35 Johnston, G. C., Pringle, J. R. & Hartwell, L. H. 1977
Coordination of growth with cell division in the yeast
Saccharomyces cerevisiae. Exp. Cell Res. 105, 79–98.
(doi:10.1016/0014-4827(77)90154-9)
36 Neufeld, T. P., la Cruz de, A. F., Johnston, L. A. &
Edgar, B. A. 1998 Coordination of growth and cell div-
ision in the Drosophila wing. Cell 93, 1183–1193.
(doi:10.1016/S0092-8674(00)81462-2)
37 Dolznig, H., Grebien, F., Sauer, T., Beug, H. & Mu ¨llner,
E. W. 2004 Evidence for a size-sensing mechanism in
animal cells. Nat. Cell Biol. 6, 899–905. (doi:10.1038/
ncb1166)
38 Weigmann, K., Cohen, S. M. & Lehner, C. F. 1997 Cell
cycle progression, growth and patterning in imaginal
discs despite inhibition of cell division after inactivation
of Drosophila Cdc2 kinase. Development 124, 3555–3563.
39 Edgar, B. A. & Datar, S. A. 1996 Zygotic degradation of
two maternal Cdc25 mRNAs terminates Drosophila’s
early cell cycle program. Genes Dev. 10, 1966–1977.
(doi:10.1101/gad.10.15.1966)
3506 P. H. O’Farrell Review. Quiescence
Phil. Trans. R. Soc. B (2011)40 Edgar, B. A. & O’Farrell, P. H. 1989 Genetic control of
cell division patterns in the Drosophila embryo. Cell 57,
177–187. (doi:10.1016/0092-8674(89)90183-9)
41 Arora, K. & Nu ¨sslein-Volhard, C. 1992 Altered mitotic
domains reveal fate map changes in Drosophila embryos
mutant for zygotic dorsoventral patterning genes.
Development 114, 1003–1024.
42 Knoblich, J. A., Sauer, K., Jones, L., Richardson, H.,
Saint, R. & Lehner, C. F. 1994 Cyclin E controls S
phase progression and its down-regulation during Droso-
phila embryogenesis is required for the arrest of cell
proliferation. Cell 77, 107–120. (doi:10.1016/0092-
8674(94)90239-9)
43 Duronio, R. J. & O’Farrell, P. H. 1994 Developmental
control of a G1–S transcriptional program in Drosophila.
Development 120, 1503–1515.
44 de Nooij, J. C., Letendre, M. A. & Hariharan, I. K. 1996
A cyclin-dependent kinase inhibitor, Dacapo, is neces-
sary for timely exit from the cell cycle during Drosophila
embryogenesis. Cell 87, 1237–1247. (doi:10.1016/
S0092-8674(00)81819-X)
45 Sigrist, S. J. & Lehner, C. F. 1997 Drosophila ﬁzzy-related
down-regulates mitotic cyclins and is required for cell
proliferation arrest and entry into endocycles. Cell 90,
671–681. (doi:10.1016/S0092-8674(00)80528-0)
46 Lane, M. E., Sauer, K., Wallace, K., Jan, Y. N., Lehner,
C. F. & Vaessin, H. 1996 Dacapo, a cyclin-dependent
kinase inhibitor, stops cell proliferation during Drosophila
development. Cell 87, 1225–1235. (doi:10.1016/S0092-
8674(00)81818-8)
47 Sprenger, F., Yakubovich, N. & O’Farrell, P. H. 1997
S-phase function of Drosophila cyclin A and its down-
regulation in G1 phase. Curr. Biol. 7, 488–499.
(doi:10.1016/S0960-9822(06)00220-X)
48 Duronio, R. J., Brook, A., Dyson, N. & O’Farrell, P. H.
1996 E2F-induced S phase requires cyclin E. Genes Dev.
10, 2505–2513. (doi:10.1101/gad.10.19.2505)
49 Shibutani, S., Swanhart, L. M. & Duronio, R. J. 2007
Rbf1-independent termination of E2f1-target gene
expression during early Drosophila embryogenesis. Devel-
opment 134, 467–478. (doi:10.1242/dev.02738)
50 Du,W.&Dyson,N.1999TheroleofRBFintheintroduc-
tion of G1 regulation during Drosophila embryogenesis.
EMBO J. 18,9 1 6–9 2 5 .( doi:10.1093/emboj/18.4.916)
51 Lehner, C. F. & O’Farrell, P. H. 1989 Expression and
function of Drosophila cyclin A during embryonic cell
cycle progression. Cell 56, 957–968. (doi:10.1016/
0092-8674(89)90629-6)
52 Lehner,C.F .&O’F arr ell,P .H.1990TherolesofDrosophila
cyclins A and B in mitotic control. Cell 61,5 3 5–5 4 7
53 Ninov, N., Manjo ´n, C. & Martı ´n-Blanco, E. 2009
Dynamic control of cell cycle and growth coupling by
ecdysone, EGFR, and PI3K signaling in Drosophila
histoblasts. PLoS Biol. 7, e1000079. (doi:10.1371/
journal.pbio.1000079)
54 Hanahan, D. & Weinberg, R. A. 2011 Hallmarks of
cancer: the next generation. Cell 144, 646–674.
(doi:10.1016/j.cell.2011.02.013)
55 Weinberg, R. A. 1995 The retinoblastoma protein and
cell cycle control. Cell 81, 323–330. (doi:10.1016/
0092-8674(95)90385-2)
56 Fang, S.-C., de los Reyes, C. & Umen, J. G. 2006 Cell
size checkpoint control by the retinoblastoma tumor sup-
pressor pathway. PLoS Genet. 2, e167. (doi:10.1371/
journal.pgen.0020167)
57 Costanzo, M. et al. 2004 CDK activity antagonizes
Whi5, an inhibitor of G1/S transcription in yeast. Cell
117, 899–913. (doi:10.1016/j.cell.2004.05.024)
58 Clarke, A. R., Maandag, E. R., van Roon, M., van der
Lugt, N. M., van der Valk, M., Hooper, M. L., Berns,
A. & te Rielef, H. 1992 Requirement for a functional
Rb-1 gene in murine development. Nature 359, 328–
330. (doi:10.1038/359328a0)
59 Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T.,
Goodell, M. A. & Weinberg, R. A. 1992 Effects of an
Rb mutation in the mouse. Nature 359, 295–300.
(doi:10.1038/359295a0)
60 Lee, E. Y., Chang, C. Y., Hu, N., Wang, Y. C., Lai, C.
C., Herrup, K., Lee, W.-H. & Bradley, A. 1992 Mice
deﬁcient for Rb are nonviable and show defects in neuro-
genesis and haematopoiesis. Nature 359, 288–294.
(doi:10.1038/359288a0)
61 Maandag, E. C., van der Valk, M., Vlaar, M., Feltkamp,
C., O’Brien, J., van Roon, M., van der Lugt, N., Berns,
A. & te Riele, H. 1994 Developmental rescue of an
embryonic-lethal mutation in the retinoblastoma gene
in chimeric mice. EMBO J. 13, 4260–4268.
62 Lipinski,M.M.,Macleod,K.F.,Williams,B.O.,Mullaney,
T .L . ,C r o w l e y ,D .&J a c k s ,T .2 0 0 1C e l l - a u t o n o m o u s
and non-cell-autonomous functions of the Rb tumor sup-
pressor in developing central nervous system. EMBO J.
20, 3402–3413. (doi:10.1093/emboj/20.13.3402)
63 Mila ´n,M.,Campuzano,S.&Garcı ´a-Bellido,A.1996Cell
cycling and patterned cell proliferation in the Drosophila
wing during metamorphosis. Proc. Natl Acad. Sci. USA
93, 11687–11692. (doi:10.1073/pnas.93.21.11687)
64 Buttitta, L. A., Katzaroff, A. J. & Edgar, B. A. 2010 A
robust cell cycle control mechanism limits E2F-induced
proliferation of terminally differentiated cells in vivo.
J. Cell Biol. 189, 981–996. (doi:10.1083/jcb.200910006)
65 Buttitta, L. A., Katzaroff, A. J., Perez, C. L., la Cruz de,
A. & Edgar, B. A. 2007 A double-assurance mechanism
controls cell cycle exit upon terminal differentiation in
Drosophila. Dev. Cell 12, 631–643. (doi:10.1016/j.
devcel.2007.02.020)
66 Reddy, B. V. V. G., Rauskolb, C. & Irvine, K. D. 2010
Inﬂuence of fat-hippo and notch signaling on the pro-
liferation and differentiation of Drosophila optic
neuroepithelia. Development 137, 2397–2408. (doi:10.
1242/dev.050013)
67 Seuwen, K., Steiner, U. & Adam, G. 1984 Cellular con-
tent of ribosomal RNA in relation to the progression and
competence signals governing proliferation of 3T3 and
SV40-3T3 cells. Exp. Cell Res. 154, 10–24. (doi:10.
1016/0014-4827(84)90664-5)
68 Molin, S., Meyenburg Von, K., Maaloe, O., Hansen,
M. T. & Pato, M. L. 1977 Control of ribosome synthesis
in Escherichia coli: analysis of an energy source shift-
down. J. Bacteriol. 131, 7–17.
69 Liko, D., Conway, M. K., Grunwald, D. S. & Heideman,
W. 2010 Stb3 plays a role in the glucose-induced transition
fromquiescencetogrowthinSaccharomycescerevisiae.Gen-
etics 185,7 9 7–8 1 0 .( doi:10.1534/genetics.110.116665)
70 Tsong, A. E., Tuch, B. B., Li, H. & Johnson, A. D. 2006
Evolution of alternative transcriptional circuits with identi-
callogic.Nature443,415–420.(doi:10.1038/nature05099)
71 Lavoie, H., Hogues, H., Mallick, J., Sellam, A., Nantel,
A. & Whiteway, M. 2010 Evolutionary tinkering with
conserved components of a transcriptional regulatory
network. PLoS Biol. 8, e1000329. (doi:10.1371/journal.
pbio.1000329)
72 Cashel, M. & Gallant, J. 1969 Two compounds impli-
cated in the function of the RC gene of Escherichia coli.
Nature 221, 838–841. (doi:10.1038/221838a0)
73 O’Farrell, P. H. 1978 The suppression of defective trans-
lation by ppGpp and its role in the stringent response.
Cell 14, 545–557. (doi:10.1016/0092-8674(78)90241-6)
74 Potrykus, K. & Cashel, M. 2008 (p)ppGpp: still magical?
Annu. Rev. Microbiol. 62, 35–51. (doi:10.1146/annurev.
micro.62.081307.162903)
Review. Quiescence P. H. O’Farrell 3507
Phil. Trans. R. Soc. B (2011)